About Fractyl Health Fractyl Health is a clinical-stage metabolic therapeutics company advancing two differentiated candidates designed to target the root causes of obesity and T2D: Revita, a procedural therapy in pivotal development for post-GLP-1 weight maintenance, and Rejuva, an AAV-based gene therapy platform with its lead candidate RJVA-001 entering first-in-human clinical studies
Addressing these fundamental questions of mechanism, delivery, and rigorous clinical validation will determine whether this remarkably versatile class of drugs can become a new pillar in the ophthalmologists armamentarium
asthma (wheezing)
The question of whether additional supplementation provides meaningful benefit on top of adequate dietary intake and normal endogenous production is exactly where the evidence gets thin
Bifidobacterium infantis Often used in infant gut support formulas, this strain helps maintain a balanced overall microbial environment
Notably, although the mechanism remains unclear, exenatide (exendin-4) did not activate vagal afferent nerves in either ex vivo or in vivo studies in rodents [3, 4]